Takeda and King Saud University Medical City Partner to Advance Healthcare Training in Saudi Arabia
Takeda, a leading global biopharmaceutical company, has announced a strategic partnership with King Saud University Medical City (KSUMC) to enhance healthcare training for medical professionals across the Kingdom of Saudi Arabia. This collaboration aims to support the Kingdom's Vision 2030 objectives by fostering knowledge exchange, advancing research, and integrating digital health and telemedicine solutions.
Focus Areas of the Collaboration
The partnership will prioritize:
- Training and Knowledge Exchange: Empowering healthcare professionals with the latest medical insights and innovations.
- Research and Development: Advancing medical research in Takeda's core therapeutic areas, including oncology, rare diseases, neuroscience, gastrointestinal and inflammation, plasma-derived therapies, and vaccines.
- Digital Health and Telemedicine: Developing cutting-edge solutions to improve patient care delivery.
The Memorandum of Collaboration (MoC) was signed during the Global Health Exhibition at Riyadh Exhibition and Convention Center, attended by Prof. Ahmed bin Salah Hirsi, CEO of KSUMC, and Dr. Khaled Sary, General Manager of Takeda West Gulf Cluster.
Strengthening Saudi Arabia’s Healthcare Sector
KSUMC, a leading medical institution in Riyadh, is known for its expert teams and advanced technologies. With over 1,300 full-time physicians, 853 residents and fellows, and 2,072 allied health personnel, the institution will leverage Takeda’s global expertise to enhance medical training and patient care.
Prof. Ahmed bin Salah Hirsi stated:
"Public-private partnerships are essential for elevating healthcare quality in line with Vision 2030. Our collaboration with Takeda will ensure healthcare practitioners are equipped with the knowledge and skills necessary to deliver exceptional patient care."
Dr. Khaled Sary added:
"By combining KSUMC’s local expertise with Takeda’s global research and development capabilities, we aim to create a resilient healthcare ecosystem that meets the evolving needs of patients. Our collaboration underscores our shared commitment to patient-centric innovation and sustainable healthcare solutions."
Commitment to Innovation and Sustainability
This partnership highlights Takeda’s dedication to addressing unmet medical needs and advancing sustainable healthcare systems. It reflects the company’s strategic focus on empowering healthcare professionals and enhancing patient outcomes through regional collaborations.
As Takeda continues to expand its partnerships across the Middle East, it remains committed to fostering innovation and building stronger healthcare ecosystems to benefit patients and communities.
